Health Care · Surgical & Medical Instruments & Apparatus · NYSE · CIK 1699350 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $23.19Day −2.23%Mkt cap $492M1Y +54.1%Off 52W high −5.7%Vol (1Y) 82.3%
Daily closing price, split-adjusted to the current basis; 1y shown of 1,165 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.0% of sh out |
| Days to cover1.8d |
| 13F net flow (QoQ)+3.59% |
| Top-10 13F concentration86.4% |
| Next report (est.)2026-09-18 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$53.9M |
| Earnings (TTM)-$44.1M |
| Net margin−85.3% |
| ROIC−50.3% |
| Debt / equity0.11× |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+62.2% |
| 1Y+54.1% |
| 3Y+54.1% |
| 5Y−77.4% |
| Since incept. (ann.)+9.6% |
Price return through 2026-07-30 · series begins 2019-11-07. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)82.3% |
| Ann. volatility (3Y)82.3% |
| Sharpe (1Y)0.92 |
| Sharpe (3Y)0.92 |
| Max drawdown (1Y)−31.3% |
| Max drawdown (3Y)−31.3% |
| Beta (3Y vs SPY)−1.75 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| FMR LLC | 3.8M | $55M | 18.33% | −1.7% |
| BlackRock, Inc. | 556,052 | $8M | 2.69% | +78.6% |
| SECTORAL ASSET MANAGEMENT INC | 430,407 | $6M | 2.08% | −12.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 413,480 | $6M | 2.00% | new |
| TimesSquare Capital Management, LLC | 322,764 | $5M | 1.56% | +11.4% |
| Roubaix Capital, LLC | 257,121 | $4M | 1.25% | +61.9% |
| Alyeska Investment Group, L.P. | 232,984 | $3M | 1.13% | +0.0% |
| Sio Capital Management, LLC | 210,641 | $3M | 1.02% | −7.6% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$0.41 | — | $16.7M | +64.9% |
| 2025-12-31 | 2026-03-10 | — | — | $14.4M | — |
| 2025-09-30 | 2025-11-12 | −$0.64 | — | $11.8M | +57.7% |
| 2025-06-30 | 2025-09-09 | −$165.53 | — | $11.0M | +33.3% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-09-18 is ESTIMATED from filing cadence (median gap 64d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
